is there a shortage on tirzepatide FDA reconsidering its decision to take off its drug list FDA resolves tirzepatide shortage, impacting

Head-to-head data from the 2025 SURMOUNT-5 trial confirms tirzepatide produces significantly more weight loss on average, though both are effective

Prepaying for a bundled package can lower the monthly cost to as low as $160 a month on the semaglutide annual plan or $240 on the tirzepatide annual plan

However, this also increases the risk of hypoglycaemia, particularly when combined with insulin or sulfonylureas

When these medications are prescribed off-label for weight loss, healthcare providers carefully consider personal or family history, medical conditions, medication adherence, and potential risks and benefits